Abbie Bown, Angela Sweed, Matthew Catton, Joshua Nelthorpe Cowne, Hermione Conti-Frith, Ruth Elderfield, Jacob Terrey, Hamsa Abib, Caleb Lui, Ella Fisher, Kevin R Bewley, Naomi S Coombes, Donna Robinson, Somya Agrawal, Bassam Hallis, Edward Blandford, Tom Fowler, Deborah A Williamson, Richard Vipond
We evaluated the performance of 12 lateral flow devices (LFDs) by assessing their analytical sensitivity for SARS-Cov-2 variant BA.2.86. Kits from ACON, Orient Gene, Xiamen Biotime, Getein and SureScreen detected variant BA.2.86 to sufficient sensitivity levels, comparable to those observed with previous Omicron variants. The stocks of LFDs currently held by the UK government do not currently need changing for deployment for this variant.
December 25, 2023: International Journal of Infectious Diseases: IJID